Develops drugs for kidney and metabolic diseases.
Dec 2024Revenue $168M/yrExpenses $110M/yr
No trend
Figures by year
Is Maze Therapeutics profitable?
Yes. In the 12 months to Dec 2024, revenue was $168M and expenses $110M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $168M | $110M | $57.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.